FDA Advisers Agree On Merits Of Mixing COVID-19 Vaccines

By Kelly Lienhard / October 15, 2021 at 5:52 PM
Members of FDA’s vaccine advisory committee seemed to agree it is important for individuals to have the option to mix and match COVID-19 vaccines, but they disagreed on what steps are needed to allow vaccine interchangeability. The discussion took place after the Vaccines and Related Biological Products Advisory Committee formally voted to allow a booster of Moderna’s and Johnson & Johnson’s COVID-19 vaccines at its Thursday (Oct 14) and Friday (Oct. 15) meetings, respectively. If FDA follows the committee’s recommendations,...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.